Wěi Li
0000-0002-9522-4474
Publication & Citation Trends
Most Cited Works
Publications
2,168 total
The dCache Domain of the Chemoreceptor Tlp1 in Campylobacter jejuni Binds and Triggers Chemotaxis toward Formate OA
Cited by 9
Semantic Scholar
DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy OA
Cited by 7
Semantic Scholar
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer PDF
Cited by 2,445
OpenAlex
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial PDF
Cited by 603
OpenAlex
Ex Vivo Chemosensitivity Profiling of Acute Myeloid Leukemia and Its Correlation With Clinical Response and Outcome to Chemotherapy OA
Cited by 9
Semantic Scholar
Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T‐Cell Acute Lymphoblastic Leukemia OA
Cited by 22
Semantic Scholar
Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia OA
Cited by 65
Semantic Scholar
DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity. OA
Cited by 11
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(124)
HER2/EGFR in Cancer Research
(120)
Synthesis and biological activity
(116)
Cancer Treatment and Pharmacology
(84)
Click Chemistry and Applications
(79)
Frequent Co-Authors
Affiliations
BGI Group (China)
Wannan Medical College
Linköping University
Rutgers, The State University of New Jersey
Xihua University